216 related articles for article (PubMed ID: 16449331)
1. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.
Perrien DS; Achenbach SJ; Bledsoe SE; Walser B; Suva LJ; Khosla S; Gaddy D
J Clin Endocrinol Metab; 2006 May; 91(5):1848-54. PubMed ID: 16449331
[TBL] [Abstract][Full Text] [Related]
2. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
3. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
[TBL] [Abstract][Full Text] [Related]
4. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.
Burger HG; Dudley EC; Hopper JL; Groome N; Guthrie JR; Green A; Dennerstein L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4025-30. PubMed ID: 10566644
[TBL] [Abstract][Full Text] [Related]
5. Inhibin and the regulation of bone mass.
Gaddy D
Curr Osteoporos Rep; 2008 Jun; 6(2):51-6. PubMed ID: 18778563
[TBL] [Abstract][Full Text] [Related]
6. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women.
Burger HG; Cahir N; Robertson DM; Groome NP; Dudley E; Green A; Dennerstein L
Clin Endocrinol (Oxf); 1998 Jun; 48(6):809-13. PubMed ID: 9713572
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition--an analysis of FSH, oestradiol and inhibin.
Burger HG
Eur J Endocrinol; 1994 Jan; 130(1):38-42. PubMed ID: 8124478
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of the relationship between follicular stimulating hormone, deoxypyridinoline, estradiol, and inhibin as decision criterion for starting replacement hormone therapy in climacteric and its correlation with symptomatology].
Carranza Lira S; Cortés Fuentes E; González Legorreta SL
Ginecol Obstet Mex; 2000 Jun; 68():242-8. PubMed ID: 10939192
[TBL] [Abstract][Full Text] [Related]
9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
10. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
11. Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause.
Landgren BM; Collins A; Csemiczky G; Burger HG; Baksheev L; Robertson DM
J Clin Endocrinol Metab; 2004 Jun; 89(6):2763-9. PubMed ID: 15181055
[TBL] [Abstract][Full Text] [Related]
12. A randomized placebo-controlled trial of short-term graded transdermal estradiol in healthy gonadotropin-releasing hormone agonist-suppressed pre- and postmenopausal women: effects on serum markers of bone turnover, insulin-like growth factor-I, and osteoclastogenic mediators.
Liu PY; Hoey KA; Mielke KL; Veldhuis JD; Khosla S
J Clin Endocrinol Metab; 2005 Apr; 90(4):1953-60. PubMed ID: 15623811
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and Follicle-Stimulating Hormone as Predictors of Onset of Menopause Transition-Related Bone Loss in Pre- and Perimenopausal Women.
Shieh A; Greendale GA; Cauley JA; Karvonen-Gutierrez C; Crandall CJ; Karlamangla AS
J Bone Miner Res; 2019 Dec; 34(12):2246-2253. PubMed ID: 31442329
[TBL] [Abstract][Full Text] [Related]
14. Serum inhibins, estradiol, progesterone and FSH in surgical menopause: a demonstration of ovarian pituitary feedback loop in women.
Muttukrishna S; Sharma S; Barlow DH; Ledger W; Groome N; Sathanandan M
Hum Reprod; 2002 Oct; 17(10):2535-9. PubMed ID: 12351524
[TBL] [Abstract][Full Text] [Related]
15. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
[TBL] [Abstract][Full Text] [Related]
16. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age.
Randolph JF; Sowers M; Bondarenko IV; Harlow SD; Luborsky JL; Little RJ
J Clin Endocrinol Metab; 2004 Apr; 89(4):1555-61. PubMed ID: 15070912
[TBL] [Abstract][Full Text] [Related]
17. Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A.
Lukefahr AL; Frye JB; Wright LE; Marion SL; Hoyer PB; Funk JL
Calcif Tissue Int; 2012 Mar; 90(3):239-49. PubMed ID: 22249524
[TBL] [Abstract][Full Text] [Related]
18. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.
Sowers MR; Greendale GA; Bondarenko I; Finkelstein JS; Cauley JA; Neer RM; Ettinger B
Osteoporos Int; 2003 May; 14(3):191-7. PubMed ID: 12730778
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women.
Wu XY; Wu XP; Xie H; Zhang H; Peng YQ; Yuan LQ; Su X; Luo XH; Liao EY
Osteoporos Int; 2010 Feb; 21(2):275-85. PubMed ID: 19562242
[TBL] [Abstract][Full Text] [Related]
20. Bone turnover across the menopause transition : The role of gonadal inhibins.
Nicks KM; Fowler TW; Akel NS; Perrien DS; Suva LJ; Gaddy D
Ann N Y Acad Sci; 2010 Mar; 1192():153-60. PubMed ID: 20392231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
